Clinical Research Directory
Browse clinical research sites, groups, and studies.
Psilocybin Therapy for Chronic Low Back Pain
Sponsor: Joshua Woolley, MD, PhD
Summary
This study evaluates whether psilocybin therapy helps patients cope with chronic low back pain more effectively. Patients may be recruited at Stanford and University of California San Francisco (UCSF), study procedures will occur at UCSF. Each participant will receive a dose of psilocybin with possibly one or more other drugs. Participants will undergo two preparation sessions, a dosing session, three integration sessions to discuss their psilocybin experience, and several follow up sessions.
Official title: A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back Pain
Key Details
Gender
All
Age Range
25 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2023-12-01
Completion Date
2026-04
Last Updated
2025-03-20
Healthy Volunteers
No
Conditions
Interventions
Psilocybin therapy with Zolpidem and Modafinil
1-30 mg (oral administration), Modafinil (oral administration), and Zolpidem (oral administration)
Psilocybin therapy with Zolpidem
1-30 mg (oral administration), Zolpidem (oral administration), and placebo (oral administration)
Psilocybin therapy with Modafinil
1-30 mg (oral administration), Modafinil (oral administration), and placebo (oral administration)
Psilocybin therapy with Placebo
1-30 mg (oral administration), and placebo (oral administration)
Locations (1)
University of California San Francisco
San Francisco, California, United States